LAVAL, Québec--(BUSINESS WIRE)--Algorithme Pharma of the Altasciences Group, a full service provider focused on early stage clinical research, today announced the addition of Dr. Graham Wood, Executive Vice President, Phase I Clinical Development to the team.
Dr. Wood will be involved in all aspects of Phase I trials conducted at Algorithme Pharma. This key appointment reinforces Algorithme Pharma’s commitment to further expand its early stage clinical research offering. It also reflects the company’s goal to remain an industry leader in innovative solutions to meet the increasingly complex requirements of biopharmaceutical companies at this critical stage of drug development.
